Advanced glycation end products (AGEs) are cross-sectionally associated with insulin secretion in healthy subjects

Amino Acids

Volumn 46, Issue 2, 2014, Pages 321-326

  Forbes, Josephine M ^a,b,c,e,h   Sourris, Karly C ^a,g   De Courten, Maximilian P J ^d,e   Dougherty, Sonia L ^a   Chand, Vibhasha ^a   Lyons, Jasmine G ^a   Bertovic, David ^a   Coughlan, Melinda T ^a,g   Schlaich, Markus P ^a   Soldatos, Georgia ^a   Cooper, Mark E ^a,e,g   Straznicky, Nora E ^a   Kingwell, Bronwyn A ^a   De Courten, Barbora ^a,d,f  

^a BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

^b MATER MEDICAL RESEARCH INSTITUTE   (Australia)

^c UNIVERSITY OF QUEENSLAND   (Australia)

^d UNIVERSITY OF COPENHAGEN   (Denmark)

^e UNIVERSITY OF MELBOURNE   (Australia)

^f STENO DIABETES CENTER   (Denmark)

^g MONASH UNIVERSITY   (Australia)

^h TRANSLATIONAL RESEARCH INSTITUTE   (Australia)

Author keywords

Central obesity; Insulin secretion; Insulin sensitivity; Type 2 diabetes

Indexed keywords

ADULT; BLOOD GLUCOSE; CROSS-SECTIONAL STUDIES; FEMALE; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; INSULIN; INSULIN RESISTANCE; MALE; RECEPTORS, IMMUNOLOGIC; YOUNG ADULT;

EID: 84895908857     PISSN: 09394451     EISSN: 14382199     Source Type: Journal    
DOI: 10.1007/s00726-013-1542-9     Document Type: Conference Paper

References (38)

1. Beisswenger BG, Delucia EM, Lapoint N, Sanford RJ, Beisswenger PJ (2005) Ketosis leads to increased methylglyoxal production on the Atkins diet. Ann N Y Acad Sci 1043:201-210
2. Bierhaus A, Haslbeck KM, Humpert PM, Liliensiek B, Dehmer T, Morcos M, Sayed AA, Andrassy M, Schiekofer S, Schneider JG, Schulz JB, Heuss D, Neundorfer B, Dierl S, Huber J, Tritschler H, Schmidt AM, Schwaninger M, Haering HU, Schleicher E, Kasper M, Stern DM, Arnold B, Nawroth PP (2004) Loss of pain perception in diabetes is dependent on a receptor of the immunoglobulin superfamily. J Clin Invest 114(12):1741-1751
3. Birlouez-Aragon I, Saavedra G, Tessier FJ, Galinier A, Ait-Ameur L, Lacoste F, Niamba CN, Alt N, Somoza V, Lecerf JM (2010) A diet based on high-heat-treated foods promotes risk factors for diabetes mellitus and cardiovascular diseases. Am J Clin Nutr 91(5):1220-1226
4. Chiavaroli V, D'Adamo E, Giannini C, de Giorgis T, De Marco S, Chiarelli F, Mohn A (2012) Serum levels of receptors for advanced glycation end products in normal-weight and obese children born small and large for gestational age. Diabetes Care 35(6):1361-1363
5. Cordain L, Eaton SB, Sebastian A, Mann N, Lindeberg S, Watkins BA, O'Keefe JH, Brand-Miller J (2005) Origins and evolution of the Western diet: health implications for the 21st century. Am J Clin Nutr 81(2):341-354
6. Coughlan MT, Forbes JM (2011) Temporal increases in urinary carboxymethyllysine correlate with albuminuria development in diabetes. Am J Nephrol 34(1):9-17
7. Coughlan MT, Yap FY, Tong DC, Andrikopoulos S, Gasser A, Thallas-Bonke V, Webster DE, Miyazaki J, Kay TW, Slattery RM, Kaye DM, Drew BG, Kingwell BA, Fourlanos S, Groop PH, Harrison LC, Knip M, Forbes JM (2011) Advanced glycation end products are direct modulators of beta-cell function. Diabetes 60(10):2523-2532
8. Forbes JM, Soderlund J, Yap FY, Knip M, Andrikopoulos S, Ilonen J, Simell O, Veijola R, Sourris KC, Coughlan MT, Forsblom C, Slattery R, Grey ST, Wessman M, Yamamoto H, Bierhaus A, Cooper ME, Groop PH (2011) Receptor for advanced glycation end-products (RAGE) provides a link between genetic susceptibility and environmental factors in type 1 diabetes. Diabetologia 54(5):1032-1042
9. Forbes JM, Cowan SP, Andrikopoulos S, Morley AL, Ward LC, Walker KZ, Cooper ME, Coughlan MT (2013) Glucose homeostasis can be differentially modulated by varying individual components of a western diet. J Nutr Biochem
10. Hagiwara S, Gohda T, Tanimoto M, Ito T, Murakoshi M, Ohara I, Yamazaki T, Matsumoto M, Horikoshi S, Funabiki K, Tomino Y (2009) Effects of pyridoxamine (K-163) on glucose intolerance and obesity in high-fat diet C57BL/6J mice. Metabolism 58(7):934-945
11. Hellwig M, Geissler S, Peto A, Knutter I, Brandsch M, Henle T (2009) Transport of free and peptide-bound pyrraline at intestinal and renal epithelial cells. J Agric Food Chem 57(14):6474-6480
12. Henle T (2005) Protein-bound advanced glycation endproducts (AGEs) as bioactive amino acid derivatives in foods. Amino Acids 29(4):313-322
13. Hofmann SM, Dong HJ, Li Z, Cai W, Altomonte J, Thung SN, Zeng F, Fisher EA, Vlassara H (2002) Improved insulin sensitivity is associated with restricted intake of dietary glycoxidation products in the db/db mouse. Diabetes 51(7):2082-2089
14. Kaneto H, Fujii J, Myint T, Miyazawa N, Islam KN, Kawasaki Y, Suzuki K, Nakamura M, Tatsumi H, Yamasaki Y, Taniguchi N (1996) Reducing sugars trigger oxidative modification and apoptosis in pancreatic beta-cells by provoking oxidative stress through the glycation reaction. Biochem J 320(Pt 3):855-863
15. Matsuoka T, Kajimoto Y, Watada H, Kaneto H, Kishimoto M, Umayahara Y, Fujitani Y, Kamada T, Kawamori R, Yamasaki Y (1997) Glycation-dependent, reactive oxygen species-mediated suppression of the insulin gene promoter activity in HIT cells. J Clin Invest 99(1):144-150
16. Miyata T, Ueda Y, Horie K, Nangaku M, Tanaka S, van Ypersele de Strihou C, Kurokawa K (1998) Renal catabolism of advanced glycation end products: the fate of pentosidine. Kidney Int 53(2):416-422
17. Nin JW, Jorsal A, Ferreira I, Schalkwijk CG, Prins MH, Parving HH, Tarnow L, Rossing P, Stehouwer CD (2011) Higher plasma levels of advanced glycation end products are associated with incident cardiovascular disease and all-cause mortality in type 1 diabetes: a 12-year follow-up study. Diabetes Care 34(2):442-447
18. Penfold SA, Coughlan MT, Patel SK, Srivastava PM, Sourris KC, Steer D, Webster DE, Thomas MC, MacIsaac RJ, Jerums G, Burrell LM, Cooper ME, Forbes JM (2010) Circulating high-molecular-weight RAGE ligands activate pathways implicated in the development of diabetic nephropathy. Kidney Int 78(3):287-295
19. Pratley RE, Weyer C (2002) Progression from IGT to type 2 diabetes mellitus: the central role of impaired early insulin secretion. Curr Diab Rep 2(3):242-248
20. Puddu A, Sanguineti R, Durante A, Viviani GL (2012) Pioglitazone attenuates the detrimental effects of advanced glycation end-products in the pancreatic beta cell line HIT-T15. Regul Pept 177(1-3):79-84
21. Riboulet-Chavey A, Pierron A, Durand I, Murdaca J, Giudicelli J, Van Obberghen E (2006) Methylglyoxal impairs the insulin signaling pathways independently of the formation of intracellular reactive oxygen species. Diabetes 55(5):1289-1299
22. Rizkalla SW, Laromiguiere M, Champ M, Bruzzo F, Boillot J, Slama G (2007) Effect of baking process on postprandial metabolic consequences: randomized trials in normal and type 2 diabetic subjects. Eur J Clin Nutr 61(2):175-183
23. Sandu O, Song K, Cai W, Zheng F, Uribarri J, Vlassara H (2005) Insulin resistance and type 2 diabetes in high-fat-fed mice are linked to high glycotoxin intake. Diabetes 54(8):2314-2319
24. Schmidt AM, Yan SD, Wautier JL, Stern D (1999) Activation of receptor for advanced glycation end products: a mechanism for chronic vascular dysfunction in diabetic vasculopathy and atherosclerosis. Circ Res 84(5):489-497
25. Sebekova K, Somoza V, Jarcuskova M, Heidland A, Podracka L (2009) Plasma advanced glycation end products are decreased in obese children compared with lean controls. Int J Pediatr Obes 4(2):112-118
26. Sourris KC, Lyons JG, de Courten MP, Dougherty SL, Henstridge DC, Cooper ME, Hage M, Dart A, Kingwell BA, Forbes JM, de Courten B (2009) c-Jun NH2-terminal kinase activity in subcutaneous adipose tissue but not nuclear factor-kappaB activity in peripheral blood mononuclear cells is an independent determinant of insulin resistance in healthy individuals. Diabetes 58(6):1259-1265
27. Sourris KC, Lyons JG, Dougherty SL, Chand V, Straznicky NE, Schlaich MP, Grima MT, Cooper ME, Kingwell BA, de Courten MP, Forbes JM, de Courten B (2013) Plasma advanced glycation end products (AGEs) and NF-kappaB activity are independent determinants of diastolic and pulse pressure. Clin Chem Lab Med 1-10
28. Stam F, Schalkwijk CG, van Guldener C, ter Wee PM, Stehouwer CD (2006) Advanced glycation end-product peptides are associated with impaired renal function, but not with biochemical markers of endothelial dysfunction and inflammation, in non-diabetic individuals. Nephrol Dial Transplant 21(3):677-682
29. Stirban A, Kotsi P, Franke K, Strijowski U, Cai W, Gotting C, Tschoepe D (2012) Acute macrovascular dysfunction in patients with type 2 diabetes mellitus induced by ingestion of advanced glycated betalactoglobulins. Diabetes Care
30. Sullivan CM, Futers TS, Barrett JH, Hudson BI, Freeman MS, Grant PJ (2005) RAGE polymorphisms and the heritability of insulin resistance: the Leeds family study. Diabetes Vasc Dis Res 2(1):42-44
31. Tian J, Avalos AM, Mao SY, Chen B, Senthil K, Wu H, Parroche P, Drabic S, Golenbock D, Sirois C, Hua J, An LL, Audoly L, La Rosa G, Bierhaus A, Naworth P, Marshak-Rothstein A, Crow MK, Fitzgerald KA, Latz E, Kiener PA, Coyle AJ (2007) Toll-like receptor 9-dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE. Nat Immunol 8(5):487-496
32. Uribarri J, Stirban A, Sander D, Cai W, Negrean M, Buenting CE, Koschinsky T, Vlassara H (2007) Single oral challenge by advanced glycation end products acutely impairs endothelial function in diabetic and nondiabetic subjects. Diabetes Care 30(10):2579-2582
33. Uribarri J, Cai W, Ramdas M, Goodman S, Pyzik R, Chen X, Zhu L, Striker GE, Vlassara H (2011) Restriction of advanced glycation end products improves insulin resistance in human type 2 diabetes: potential role of AGER1 and SIRT1. Diabetes Care 34(7):1610-1616
34. Vaaler S, Hanssen KF, Aagenaes O (1984) The effect of cooking upon the blood glucose response to ingested carrots and potatoes. Diabetes Care 7(3):221-223
35. Vlassara H, Striker LJ, Teichberg S, Fuh H, Li YM, Steffes M (1994) Advanced glycation end products induce glomerular sclerosis and albuminuria in normal rats. Proc Natl Acad Sci USA 91(24):11704-11708
36. Weyer C, Tataranni PA, Bogardus C, Pratley RE (2001) Insulin resistance and insulin secretory dysfunction are independent predictors of worsening of glucose tolerance during each stage of type 2 diabetes development. Diabetes Care 24(1):89-94
37. Yamamoto Y, Kato I, Doi T, Yonekura H, Ohashi S, Takeuchi M, Watanabe T, Yamagishi S, Sakurai S, Takasawa S, Okamoto H, Yamamoto H (2001) Development and prevention of advanced diabetic nephropathy in RAGE-overexpressing mice. J Clin Invest 108(2):261-268
38. Zong H, Madden A, Ward M, Mooney MH, Elliott CT, Stitt AW (2010) Homodimerization is essential for the receptor for advanced glycation end products (RAGE)-mediated signal transduction. J Biol Chem 285(30):23137-23146